A multi-omics dataset for the analysis of frontotemporal dementia genetic subtypes
-
Published:2023-12-01
Issue:1
Volume:10
Page:
-
ISSN:2052-4463
-
Container-title:Scientific Data
-
language:en
-
Short-container-title:Sci Data
Author:
Menden KevinORCID, Francescatto Margherita, Nyima Tenzin, Blauwendraat CornelisORCID, Dhingra Ashutosh, Castillo-Lizardo Melissa, Fernandes Noémia, Kaurani Lalit, Kronenberg-Versteeg Deborah, Atasu Burcu, Sadikoglou Eldem, Borroni Barbara, Rodriguez-Nieto Salvador, Simon-Sanchez Javier, Fischer Andre, Craig David Wesley, Neumann Manuela, Bonn StefanORCID, Rizzu PatriziaORCID, Heutink PeterORCID
Abstract
AbstractUnderstanding the molecular mechanisms underlying frontotemporal dementia (FTD) is essential for the development of successful therapies. Systematic studies on human post-mortem brain tissue of patients with genetic subtypes of FTD are currently lacking. The Risk and Modyfing Factors of Frontotemporal Dementia (RiMod-FTD) consortium therefore has generated a multi-omics dataset for genetic subtypes of FTD to identify common and distinct molecular mechanisms disturbed in disease. Here, we present multi-omics datasets generated from the frontal lobe of post-mortem human brain tissue from patients with mutations in MAPT, GRN and C9orf72 and healthy controls. This data resource consists of four datasets generated with different technologies to capture the transcriptome by RNA-seq, small RNA-seq, CAGE-seq, and methylation profiling. We show concrete examples on how to use the resulting data and confirm current knowledge about FTD and identify new processes for further investigation. This extensive multi-omics dataset holds great value to reveal new research avenues for this devastating disease.
Funder
NOMIS Stiftung EU Joint Programme – Neurodegenerative Disease Research
Publisher
Springer Science and Business Media LLC
Subject
Library and Information Sciences,Statistics, Probability and Uncertainty,Computer Science Applications,Education,Information Systems,Statistics and Probability
Reference29 articles.
1. Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. The Lancet 386, 1672–1682 (2015). 2. Panza, F. et al. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nat. Rev. Neurol. 16, 213–228 (2020). 3. Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C. & van Swieten, J. C. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J. Neurol. Neurosurg. Psychiatry 82, 476–486 (2011). 4. Olszewska, D. A., Lonergan, R., Fallon, E. M. & Lynch, T. Genetics of Frontotemporal Dementia. Current Neurology and Neuroscience Reports vol. 16 (2016). 5. Sirkis, D. W., Geier, E. G., Bonham, L. W., Karch, C. M. & Yokoyama, J. S. Recent Advances in the Genetics of Frontotemporal Dementia. Curr. Genet. Med. Rep. 7, 41–52 (2019).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|